The effect of dopamine receptor agonists on the spontaneous bioelectrical activity of CA1 layer neurons in the hippocampal slice preparation from the rat brain was studied. Two groups of rats were used: control and imipramine-pretreated ones (twice a day, for two weeks, 10 mg/kg PO). Dopamine and the selective D2 receptor agonist quinpirole induced an excitatory reaction; a similar effect was evoked by amphetamine, an indirect dopamine agonist. The effects of the three compounds were diminished by sulpiride. Perfusion of control slices with imipramine decreased the excitatory effect of dopamine, amphetamine, and quinpirole. The effect of dopamine agonists was also inhibited 2 h after repeated pretreatment with imipramine. The excitatory effect of the dopamine agonist was enhanced 48 h after the last dose of imipramine, the latter effect was blocked by a 60-min perfusion of slices with imipramine or sulpiride in the experimental chamber. The obtained data show that acute imipramine induces blockade of dopamine D2 receptors in the hippocampus. This effect is probably responsible for development of supersensitivity of dopamine D2 mechanisms after prolonged treatment with imipramine in this brain region.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/0091-3057(91)90404-p | DOI Listing |
Biosens Bioelectron
January 2025
Centre for Advanced Optoelectronic Functional Materials Research and Key Laboratory of UV Light-Emitting Materials and Technology of Ministry of Education, Northeast Normal University, 130024, Changchun, China. Electronic address:
The development of integrated multiple signal outputs within a single platform is highly significant for efficient and accurate on-site biomarker detection. Herein, colorimetric/electrochemical dual-mode microfluidic paper-based analytical devices (μPADs) were designed for portable, visual and accurate dopamine (DA) detection. The dual-mode μPADs, featuring folded structure, integrate a colorimetric layer and an electrochemical layer using wax printing and laser-induced graphene (LIG) pyrolysis techniques, allowing the vertical flow of analyte solution.
View Article and Find Full Text PDFBraz J Biol
January 2025
Universidade Federal da Paraíba, João Pessoa, PB, Brasil.
Parkinson's disease (PD) is characterized by progressive loss of dopaminergic neurons in the substantia nigra pars compacta, which leads to a reduction in the production of dopamine. Medication with levodopa becomes less effective as the disease progresses. Despite the excellent results observed in clinical practice with the medicinal use of Cannabis in the treatment of PD, the level of scientific evidence is still limited due to the small number of studies published in this field.
View Article and Find Full Text PDFActa Neurol Belg
January 2025
The Department of Neurological Institute, Taichung Veterans General Hospital, Taichung, Taiwan.
Parkinson's disease (PD) is characterized by motor and non-motor symptoms, including olfactory dysfunction. Prior studies have shown that olfaction deteriorates with disease progression, however fluctuations in olfaction and related PD symptoms have been less explored. This study aimed to investigate correlations between changes in odor identification ability and PD symptoms.
View Article and Find Full Text PDFElife
January 2025
Max Planck Institute for Metabolism Research, Department of Neuronal Control of Metabolism, Cologne, Germany.
Orexin signaling in the ventral tegmental area and substantia nigra promotes locomotion and reward processing, but it is not clear whether dopaminergic neurons directly mediate these effects. We show that dopaminergic neurons in these areas mainly express orexin receptor subtype 1 (Ox1R). In contrast, only a minor population in the medial ventral tegmental area express orexin receptor subtype 2 (Ox2R).
View Article and Find Full Text PDFAm J Nucl Med Mol Imaging
December 2024
Department of Radiology, University of Pennsylvania Philadelphia, PA 19104, USA.
This review assesses the primary neuroimaging techniques used to evaluate Parkinson's disease (PD) - a neurological condition characterized by gradual dopamine-producing nerve cell degeneration. The neuroimaging techniques explored include positron emission tomography (PET), single-photon emission computed tomography (SPECT), and magnetic resonance imaging (MRI). These modalities offer varying degrees of insights into PD pathophysiology, diagnostic accuracy, specificity by way of exclusion of other Parkinsonian syndromes, and monitoring of disease progression.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!